Precision Genomics Collaboratory News

ilis, Inc., a pioneering company using its MicroOrganoSphere (MOS) technology to guide precision therapy for cancer patients and accelerate drug discovery and development, today announced the close of a $70 million Series A financing.

In a paper published in Nature, a cancer-like mutation was linked to cerebral cavernous malformations (CCMs), a condition in which blood vessels in the brain are formed abnormally. Currently, the condition can only be treated by means of surgery however the discovery of the mutation has the potential to develop novel therapeutic strategies.

Two faculty in the Precision Genomics Collaboratory have been honored with distinguished professorships.

This issue includes

• Funding opportunities from the Precision Genomics Collaboratory
• News updates from the genomics community
• Featured publications
• Duke funding opportunities of potential interest
• Upcoming events

Read the newsletter

Priya Kishnani, MD, HS'91-'95, is the Chen Family Distinguished Professor of Pediatrics, chief of the Division of Medical Genetics, a professor in the Department of Molecular Genetics and Microbiology, core faculty member of the Duke Innovation and Entrepreneurship Initiatives, and member of the Duke Clinical Research Institute.

As a pediatrician, Sarah Armstrong, MD, has devoted her career to improving children’s health and well-being.

Dr. Priya Kishnani grew up in a family of physicians, including her mother, a pediatrician, in Mumbai (then Bombay), India. “My mother ran a charitable program, caring for the underserved and indigent throughout her life,” Dr. Kishnani says. “I saw firsthand what it really meant to be a physician: to give hope to your neighbors, and make an impact on the rest of their lives. From then on, I knew this was what I wanted to do.”

Three Duke University School of Medicine researchers were named Burroughs Wellcome Fund 2021 Investigators in the highly competitive Pathogenesis of Infectious Disease (PATH) program.

A new $8 million NIH grant seeks to uncover more clues into what genes increase the risk of developing schizophrenia.

The Sequencing and Genomic Technologies (SGT) Core Facility has a new instrument on its bench